… to making an early diagnosis or predicting the response to specific therapies. This review
aims to critically discuss the current therapeutic strategies for OC, novel drug-delivery systems, …

… and promising molecular targeted drugs in ovarian cancer is bevacizumab, a … ovarian cancer
patients, however, investigation of molecular targeting drugs in patients with ovarian cancer …

Of all the gynecologic tumors, ovarian cancer (OC) is known to be the deadliest. Advanced‐stages
of OC are linked with high morbidity and low survival rates despite the immense …

… for therapy. Thus, targeting the morphomolecular ovarian cancer type is one important strategy…
This article discusses each of these strategies with concrete examples for ovarian cancer. …

… the promise of turning ovarian cancer into a manageable chronic … the therapy for ovarian
cancer, major recent studies on the new variants of conventional therapies, and new therapeutic …

… resistance to therapy and when this occurs, ovarian cancer is currently incurable. Hence,
there is an urgent need to develop smarter treatment options. Epithelial ovarian cancer (EOC) …

… arise from cells that make up the epithelial layer that covers the surface of the ovaries. …
cancers. In general, when the term ovarian cancer is used, it implies epithelial ovarian cancer, the …

… ovarian CSCs, ALDH+ ovarian cancer cells exhibit stem cell-like properties, and knock-down
of ALDH1A1 in ovarian cancer … a feasible therapeutic strategy for ovarian cancer (Figure 2). …

… With the identification of mutations common to a majority of neoplasms, therapeutic strategies
can be designed that will correct these defects in vivo and allow testing in clinical trials. …

… present potential therapeutic target for ovarian cancer. Here, … and ovarian cancer and various
therapies targeting the tumor … TME and ovarian cancer and various therapies targeting the …